BREAKING: NASDAQ stock shows “100% survival rate” on new COVID-19 treatment

Pluristem Therapeutics Inc. (NASDAQ: PSTI) has made groundbreaking progress in the treatment for COVID-19 in treating severely ill patients. Pluristem uses PLX stem therapy on patients that have critical complications due to COVID-19. The Israeli based biotech released a statement on Monday : confirming they had been cleared by the FDA to proceed with the treatment in U.S.,Read more